1. Home
  2. GPCR vs WGO Comparison

GPCR vs WGO Comparison

Compare GPCR & WGO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • GPCR
  • WGO
  • Stock Information
  • Founded
  • GPCR 2016
  • WGO 1958
  • Country
  • GPCR United States
  • WGO United States
  • Employees
  • GPCR N/A
  • WGO N/A
  • Industry
  • GPCR
  • WGO Homebuilding
  • Sector
  • GPCR
  • WGO Industrials
  • Exchange
  • GPCR Nasdaq
  • WGO Nasdaq
  • Market Cap
  • GPCR 1.1B
  • WGO 893.6M
  • IPO Year
  • GPCR 2023
  • WGO N/A
  • Fundamental
  • Price
  • GPCR $19.61
  • WGO $36.27
  • Analyst Decision
  • GPCR Strong Buy
  • WGO Buy
  • Analyst Count
  • GPCR 9
  • WGO 11
  • Target Price
  • GPCR $75.63
  • WGO $39.60
  • AVG Volume (30 Days)
  • GPCR 898.3K
  • WGO 566.8K
  • Earning Date
  • GPCR 08-06-2025
  • WGO 06-25-2025
  • Dividend Yield
  • GPCR N/A
  • WGO 3.76%
  • EPS Growth
  • GPCR N/A
  • WGO N/A
  • EPS
  • GPCR N/A
  • WGO N/A
  • Revenue
  • GPCR N/A
  • WGO $2,741,800,000.00
  • Revenue This Year
  • GPCR N/A
  • WGO N/A
  • Revenue Next Year
  • GPCR N/A
  • WGO $5.77
  • P/E Ratio
  • GPCR N/A
  • WGO N/A
  • Revenue Growth
  • GPCR N/A
  • WGO N/A
  • 52 Week Low
  • GPCR $13.22
  • WGO $28.00
  • 52 Week High
  • GPCR $45.37
  • WGO $65.65
  • Technical
  • Relative Strength Index (RSI)
  • GPCR 56.57
  • WGO 66.35
  • Support Level
  • GPCR $18.39
  • WGO $33.12
  • Resistance Level
  • GPCR $21.44
  • WGO $35.53
  • Average True Range (ATR)
  • GPCR 1.18
  • WGO 1.28
  • MACD
  • GPCR 0.31
  • WGO 0.44
  • Stochastic Oscillator
  • GPCR 67.60
  • WGO 97.99

About GPCR Structure Therapeutics Inc.

Structure Therapeutics Inc is a clinical-stage biopharmaceutical company developing novel oral small-molecule therapeutics to treat a wide range of chronic diseases with unmet medical needs. Its differentiated technology platform leverages both structure-based drug discovery and expertise in computational chemistry to discover and develop small molecule therapeutics against G-protein coupled receptors (GPCRs). The group operates and manages its business as one reportable and operating segment, which is the business of research and development of medicines that target chronic diseases with unmet medical needs.

About WGO Winnebago Industries Inc.

Winnebago Industries manufactures Class A, B, and C motor homes along with towables, customized specialty vehicles, boats, and parts. Headquartered in Eden Prairie, Minnesota, Winnebago has been producing recreational vehicles since 1958. Revenue was nearly $3 billion in fiscal 2024. Winnebago expanded into towables in 2011 with the acquisition of SunnyBrook and acquired Grand Design in November 2016. Towables made up 83% of the firm's RV unit volume, up from 31% in fiscal 2016. The company's total RV unit volume was 38,796 in fiscal 2024. Winnebago expanded into boating in 2018 with the purchase of Chris-Craft, bought premium motor home maker Newmar in November 2019, and bought Barletta pontoon boats in August 2021. It also is developing electric and autonomous technology.

Share on Social Networks: